R-56865

N/A

Report date: 2022/02/21 10:51:13
NME

Base Information

Drug NameR-56865
Drug Alias NameR-56865
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersVoltage-gated calcium channel blockers
TargetsSodium channel alpha subunitVoltage-gated calcium channel
Therapy Area/IndicationsMyocardial IschemiaArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Innovative Medicine
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A